The PrEPWatch Resource Database offers a wide range of material on the status of PrEP as an option for biomedical HIV prevention around the world. Search this database to find step-by-step guidance for rolling out PrEP, summaries of the research to date on safety, efficacy and implementation, tools to assist planning and roll out, country updates on PrEP policy and access, and lessons learned from those efforts.
Showing results 1 - 10 of 645
Differentiated HIV Services for Transgender People in Four South African Districts: Population characteristics and HIV care cascade
This article from the Journal of the International AIDS Society describes a differentiated service delivery model across four South African sites and transgender individuals who access these services. It assesses whether hormone therapy is associated with continued use of PrEP and viral load suppression.
Research, Service Delivery
Travestis, Transgender Women and Young MSM are at High Risk for PrEP Early Loss to Follow-up in Rio de Janeiro, Brazil
This article from the Brazilian Journal of Infectious Diseases identifies factors associated with PrEP early loss to follow-up among gay, bisexual and other men who have sex with men, travestis, and transgender women in Rio de Janeiro, Brazil.
Monitoring & Evaluation, Service Delivery
PrEP Risk Perception and Adherence among Men who have Sex with Men: A prospective cohort study based on growth mixture model
This study from BMC Infectious Diseases explores PrEP risk perception among gay and bisexual men who have sex with men in western China and its impact on PrEP adherence.
Monitoring & Evaluation, Service Delivery
A Capacity-Strengthening Intervention to Support HIV Pre-exposure Prophylaxis (PrEP) Awareness-Building and Promotion by Frontline Harm Reduction Workers in Baltimore, Maryland: A mixed methods evaluation
This article from AIDS and Behavior describes the results of an intervention to increase knowledge and awareness of PrEP amongst people who inject drugs in Baltimore, Maryland, USA.
Demand Creation/Marketing, Service Delivery
Southern African HIV Clinicians Society PrEP Training Curriculum
This training curriculum was developed by the Southern African HIV Clinicians Society to support implementers rolling out PrEP. Module 1a: A basic overview and introduction to PrEP Module 1b: Evidence of PrEP effectiveness Module 2: Providing PrEP- the basics Module 3a: Overview of key populations Module 3b: Gay and bisexual men who have sex with…
Demand Creation/Marketing, Research, Service Delivery
Costs and Cost-Effectiveness of Biomedical, Non-Surgical HIV Prevention Interventions: A systematic literature review
This article from PharmacoEconomics synthesizes findings on cost and cost-effectivness of different biomedical HIV prevention options and identifies remaining knowledge gaps to suggest future research priorities.
Financing & Costing, Research
Barriers to PrEP Uptake among Black Female Adolescents and Emerging Adults
This article from Preventative Medicine Reports examines the characteristics of age, race, gender, history, and medical mistrust as barriers to PrEP uptake among Black female adolescents and emerging adults between the ages of 13–24 years in Chicago, Illinois, USA.
Event-Driven PrEP Guidance (French)
This French-language infographic explains how and when to take event-driven PrEP.
Guidelines on Use of ARV Drugs for Treating and Preventing HIV Infections in Kenya (2018)
These guidelines from Kenya’s National AIDS & STI Control Program (NASCOP) cover HIV testing services and linkage to prevention and treatment; initial evaluation and follow up of People Living with HIV (PLHIV); standard package of care for PLHIV; adherence preparation monitoring and support; antiretroviral therapy in infants, children, adolescents and adults; prevention of mother to…
Long-acting HIV Pre-exposure Prophylaxis (PrEP) Approaches: Recent advances, emerging technologies, and development challenges
This review from Expert Opinion on Drug Delivery discusses the current state of the long acting PrEP field, recent advances, and emerging technologies, including ARV prodrug modifications and new drug delivery systems. Technological challenges, knowledge gaps, preclinical testing considerations, and future directions important in the context of clinical translation and implementation of long acting HIV…